Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1/2 Study of Picoplatin and Docetaxel (With Prednisone) in Subjects With Chemotherapy-Naive Metastatic Hormone-Refractory Prostate Cancer

NCT00448734 is registered in ClinicalTrials.gov with Poniard Pharmaceuticals as lead sponsor.

NCT NCT00448734
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00448734 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1/2 Study of Picoplatin and Docetaxel (With Prednisone) in Subjects With Chemotherapy-Naive Metastatic Hormone-Refractory Prostate Cancer
Lead sponsor
Poniard Pharmaceuticals
Phase
Phase 1/2
Overall status
Unknown status
Start date
June 30, 2006
Completion date
July 31, 2010
Enrollment
95 (estimated)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

hormone refractory prostate cancer